Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDySunao Kojima, Hisao Ogawa, Yutaka Wakasa et al.|European Heart Journal|2019Cited by 229
Rationale, design, and baseline characteristics of a study to evaluate the effect of febuxostat in preventing cerebral, cardiovascular, and renal events in patients with hyperuricemiaSunao Kojima, Yoshihiko Saito, Kunihiko Matsui et al.|Journal of Cardiology|2016Cited by 43
Effect of febuxostat on clinical outcomes in patients with hyperuricemia and cardiovascular diseaseMasaaki Konishi, Hisao Ogawa, Sunao Kojima et al.|International Journal of Cardiology|2021Cited by 38
Triglyceride/low-density-lipoprotein cholesterol ratio is the most valuable predictor for increased small, dense LDL in type 2 diabetes patientsGen Ouchi, Yusuke Ohya|Lipids in Health and Disease|2022Cited by 38